Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


28.05.2018

1 AJR Am J Roentgenol
2 Am J Clin Oncol
2 Ann Oncol
3 Ann Surg Oncol
3 BMC Cancer
1 Breast Cancer
1 Breast Cancer Res
2 Breast Cancer Res Treat
7 Breast J
2 Cancer Chemother Pharmacol
1 Cancer Epidemiol Biomarkers Prev
2 Cancer Lett
3 Clin Breast Cancer
1 Exp Cell Res
1 Gene
1 Int J Cancer
4 J Clin Oncol
2 J Natl Cancer Inst
1 J Surg Oncol
5 PLoS One
7 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. JIANG Y, Inciardi MF, Edwards AV, Papaioannou J, et al
    Interpretation Time Using a Concurrent-Read Computer-Aided Detection System for Automated Breast Ultrasound in Breast Cancer Screening of Women With Dense Breast Tissue.
    AJR Am J Roentgenol. 2018 May 24:1-10. doi: 10.2214/AJR.18.19516.
    PubMed     Text format     Abstract available


    Am J Clin Oncol

  2. ARLOW RL, Paddock LE, Niu X, Kirstein L, et al
    Breast-conservation Therapy After Neoadjuvant Chemotherapy Does Not Compromise 10-Year Breast Cancer-specific Mortality.
    Am J Clin Oncol. 2018 May 18. doi: 10.1097/COC.0000000000000456.
    PubMed     Text format     Abstract available

  3. ZAVITSANOS PJ, Wazer DE, Hepel JT, Wang Y, et al
    BRCA1 Mutations Associated With Increased Risk of Brain Metastases in Breast Cancer: A 1: 2 Matched-pair Analysis.
    Am J Clin Oncol. 2018 May 18. doi: 10.1097/COC.0000000000000466.
    PubMed     Text format     Abstract available


    Ann Oncol

  4. LIU C, Wang L, Zhuang J, Liu L, et al
    Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis.
    Ann Oncol. 2018;29:1329-1330.
    PubMed     Text format    

  5. GAGE MM, Mylander WC, Rosman M, Fujii T, et al
    Combined pathologic-genomic algorithm for early-stage breast cancer improves cost-effective use of the 21-gene recurrence score assay.
    Ann Oncol. 2018;29:1280-1285.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  6. MURPHY BL, Day CN, Hoskin TL, Habermann EB, et al
    Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes.
    Ann Surg Oncol. 2018 May 21. pii: 10.1245/s10434-018-6531.
    PubMed     Text format     Abstract available

  7. SORAN A, Ozmen V, Ozbas S, Karanlik H, et al
    Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01.
    Ann Surg Oncol. 2018 May 17. pii: 10.1245/s10434-018-6494.
    PubMed     Text format     Abstract available

  8. SCHUMACHER JR, Neuman HB, Chang GJ, Kozower BD, et al
    A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01).
    Ann Surg Oncol. 2018 May 17. pii: 10.1245/s10434-018-6496.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. PARASHAR S, Cheishvili D, Mahmood N, Arakelian A, et al
    DNA methylation signatures of breast cancer in peripheral T-cells.
    BMC Cancer. 2018;18:574.
    PubMed     Text format     Abstract available

  10. BUCZEK E, Denslow A, Mateuszuk L, Proniewski B, et al
    Alterations in NO- and PGI2- dependent function in aorta in the orthotopic murine model of metastatic 4T1 breast cancer: relationship with pulmonary endothelial dysfunction and systemic inflammation.
    BMC Cancer. 2018;18:582.
    PubMed     Text format     Abstract available

  11. FORTE L, Turdo F, Ghirelli C, Aiello P, et al
    The PDGFRbeta/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer.
    BMC Cancer. 2018;18:586.
    PubMed     Text format     Abstract available


    Breast Cancer

  12. LEE SB, Sohn G, Kim J, Chung IY, et al
    Survival analysis according to period and analysis of the factors influencing changes in survival in patients with recurrent breast cancer: a large-scale, single-center study.
    Breast Cancer. 2018 May 21. pii: 10.1007/s12282-018-0869.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  13. JOHNSTON AN, Bu W, Hein S, Garcia S, et al
    Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.
    Breast Cancer Res. 2018;20:42.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  14. MASUMOTO N, Kadoya T, Sasada S, Emi A, et al
    Intratumoral heterogeneity on dedicated breast positron emission tomography predicts malignancy grade of breast cancer.
    Breast Cancer Res Treat. 2018 May 19. pii: 10.1007/s10549-018-4791.
    PubMed     Text format     Abstract available

  15. LI D, McCall LM, Hahn OM, Hudis CA, et al
    Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study.
    Breast Cancer Res Treat. 2018 May 22. pii: 10.1007/s10549-018-4828.
    PubMed     Text format     Abstract available


    Breast J

  16. MELNOV S, Murphy P, Foley T, Nadyrov E, et al
    Somatic hematopoietic TP53 mosaicism in women with breast cancer exposed to ionizing radiation.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13056.
    PubMed     Text format    

  17. CAUGHRAN J, Braun TM, Breslin TM, Smith DR, et al
    The Effect of the 2009 USPSTF breast cancer screening recommendations on breast cancer in Michigan: A longitudinal study.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13034.
    PubMed     Text format     Abstract available

  18. MANSOORI Y, Tabei MB, Askari A, Izadi P, et al
    Expression levels of breast cancer-related GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: Molecular associations with age at menarche and obesity.
    Breast J. 2018 May 21. doi: 10.1111/tbj.13067.
    PubMed     Text format     Abstract available

  19. BALAGAMWALA EH, Manyam BV, Leyrer CM, Karthik N, et al
    Most patients are eligible for an alternative to conventional whole breast irradiation for early-stage breast cancer: A National Cancer Database Analysis.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13051.
    PubMed     Text format     Abstract available

  20. MARIANI M, George K
    Neuropsychological and self-reporting outcomes following rehabilitation of cognitive dysfunction in survivors of breast cancer: A pilot study involving survivor-partner dyads.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13060.
    PubMed     Text format    

  21. BELAID I, Fatma LB, Ezzairi F, Hochlaf M, et al
    Trends and current challenges of breast cancer in Tunisia: a retrospective study of 1262 cases with survival analysis.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13062.
    PubMed     Text format    

  22. WHITE MC, Soman A, Weinberg CR, Rodriguez JL, et al
    Factors associated with breast MRI use among women with a family history of breast cancer.
    Breast J. 2018 May 20. doi: 10.1111/tbj.13063.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  23. LEUNG HW, Ko CH, Yue GG, Herr I, et al
    The natural agent 4-vinylphenol targets metastasis and stemness features in breast cancer stem-like cells.
    Cancer Chemother Pharmacol. 2018 May 18. pii: 10.1007/s00280-018-3601.
    PubMed     Text format     Abstract available

  24. HUANG JF, Wen CJ, Zhao GZ, Dai Y, et al
    Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro.
    Cancer Chemother Pharmacol. 2018 May 18. pii: 10.1007/s00280-018-3603.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  25. PARL FF, Crooke PS, Plummer WD, Dupont WD, et al
    Genomic-Epidemiologic Evidence that Estrogens Promote Breast Cancer Development.
    Cancer Epidemiol Biomarkers Prev. 2018 May 22. pii: 1055-9965.EPI-17-1174.
    PubMed     Text format     Abstract available


    Cancer Lett

  26. LI Y, Huang J, Zeng B, Yang D, et al
    PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation.
    Cancer Lett. 2018 May 16. pii: S0304-3835(18)30343.
    PubMed     Text format     Abstract available

  27. SOHN EJ, Jung DB, Lee H, Han I, et al
    Corrigendum to "CNOT2 promotes proliferation and angiogenesis via VEGF signaling in MDA-MB-231 breast cancer cells" [Cancer Lett 412 (2018 Jan 1) 88-98].
    Cancer Lett. 2018 May 19. pii: S0304-3835(18)30321.
    PubMed     Text format    


    Clin Breast Cancer

  28. DHAKAL A, Matthews CM, Levine EG, Salerno KE, et al
    Efficacy of Palbociclib Combinations in Hormone Receptor-Positive Metastatic Breast Cancer Patients After Prior Everolimus Treatment.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(17)30805.
    PubMed     Text format     Abstract available

  29. LADWA R, Kalas T, Pathmanathan S, Woodward N, et al
    Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(18)30105.
    PubMed     Text format     Abstract available

  30. KOPS NL, Bessel M, Caleffi M, Ribeiro RA, et al
    Body Weight and Breast Cancer: Nested Case-Control Study in Southern Brazil.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(18)30073.
    PubMed     Text format     Abstract available


    Exp Cell Res

  31. DING J, Xu Z, Zhang Y, Tan C, et al
    Exosome-mediated miR-222 Transferring: An insight into NF-kappaB-mediated Breast Cancer Metastasis.
    Exp Cell Res. 2018 May 17. pii: S0014-4827(18)30276.
    PubMed     Text format     Abstract available


    Gene

  32. RAHMAN S, Zayed H
    Breast cancer in the GCC countries: A focus on BRCA1/2 and non-BRCA1/2 genes.
    Gene. 2018 May 16. pii: S0378-1119(18)30534-1. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    Int J Cancer

  33. VON NEUBECK B, Gondi G, Riganti C, Pan C, et al
    An inhibitory antibody targeting Carbonic Anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo.
    Int J Cancer. 2018 May 22. doi: 10.1002/ijc.31607.
    PubMed     Text format     Abstract available


    J Clin Oncol

  34. FASCHING PA, Loibl S, Hu C, Hart SN, et al
    BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study.
    J Clin Oncol. 2018 May 23:JCO2017772285. doi: 10.1200/JCO.2017.77.2285.
    PubMed     Text format     Abstract available

  35. TAYLOR C, McGale P, Bronnum D, Correa C, et al
    Cardiac Structure Injury After Radiotherapy for Breast Cancer: Cross-Sectional Study With Individual Patient Data.
    J Clin Oncol. 2018 May 23:JCO2017776351. doi: 10.1200/JCO.2017.77.6351.
    PubMed     Text format     Abstract available

  36. DENDULURI N, Chavez-MacGregor M, Telli ML, Eisen A, et al
    Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update.
    J Clin Oncol. 2018 May 22:JCO2018788604. doi: 10.1200/JCO.2018.78.8604.
    PubMed     Text format     Abstract available

  37. THAVENDIRANATHAN P, Abdel-Qadir H, Fischer HD, Liu Y, et al
    Risk-Imaging Mismatch in Cardiac Imaging Practices for Women Receiving Systemic Therapy for Early-Stage Breast Cancer: A Population-Based Cohort Study.
    J Clin Oncol. 2018 May 23:JCO2018779736. doi: 10.1200/JCO.2018.77.9736.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  38. PATTERSON RE, Marinac CR, Sears DD, Kerr J, et al
    The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes.
    J Natl Cancer Inst. 2018 May 18. pii: 4999668. doi: 10.1093.
    PubMed     Text format     Abstract available

  39. LOHMANN AE, Pimentel I, Goodwin PJ
    Novel Insights Into the Impact of Lifestyle-Based Weight Loss and Metformin on Obesity-Associated Biomarkers in Breast Cancer.
    J Natl Cancer Inst. 2018 May 18. pii: 4999672. doi: 10.1093.
    PubMed     Text format    


    J Surg Oncol

  40. SHEN S, Xu Q, Zhou Y, Mao F, et al
    Comparison of sentinel lymph node biopsy guided by blue dye with or without indocyanine green in early breast cancer.
    J Surg Oncol. 2018 May 22. doi: 10.1002/jso.25058.
    PubMed     Text format     Abstract available


    PLoS One

  41. RACCAGNI I, Belloli S, Valtorta S, Stefano A, et al
    [18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer.
    PLoS One. 2018;13:e0197754.
    PubMed     Text format     Abstract available


  42. Retraction: Calcium Channel Blockers and Risk of Breast Cancer: A Meta-Analysis of 17 Observational Studies.
    PLoS One. 2018;13:e0198220.
    PubMed     Text format    

  43. STRUIK GM, Vrijland WW, Birnie E, Klem TMAL, et al
    A randomized controlled trial on the effect of a silver carboxymethylcellulose dressing on surgical site infections after breast cancer surgery.
    PLoS One. 2018;13:e0195715.
    PubMed     Text format     Abstract available

  44. HUBBELING HG, Rosenberg SM, Gonzalez-Robledo MC, Cohn JG, et al
    Psychosocial needs of young breast cancer survivors in Mexico City, Mexico.
    PLoS One. 2018;13:e0197931.
    PubMed     Text format     Abstract available

  45. PAVANELLO S, Varesco L, Gismondi V, Bruzzi P, et al
    Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study.
    PLoS One. 2018;13:e0197522.
    PubMed     Text format     Abstract available


    Radiology

  46. MAZARI FAK, Sharma N, Dodwell D, Horgan K, et al
    Human Epidermal Growth Factor 2-positive Breast Cancer with Mammographic Microcalcification: Relationship to Pathologic Complete Response after Neoadjuvant Chemotherapy.
    Radiology. 2018 May 16:170960. doi: 10.1148/radiol.2018170960.
    PubMed     Text format     Abstract available

  47. PINKER K, Chin J, Melsaether AN, Morris EA, et al
    Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment.
    Radiology. 2018;287:732-747.
    PubMed     Text format     Abstract available

  48. GAO Y, Albert M, Young Lin LL, Lewin AA, et al
    What Happens after a Diagnosis of High-Risk Breast Lesion at Stereotactic Vacuum-assisted Biopsy? An Observational Study of Postdiagnosis Management and Imaging Adherence.
    Radiology. 2018 Jan 29:171665. doi: 10.1148/radiol.2017171665.
    PubMed     Text format     Abstract available

  49. ELEZABY M, Li G, Bhargavan-Chatfield M, Burnside ES, et al
    ACR BI-RADS Assessment Category 4 Subdivisions in Diagnostic Mammography: Utilization and Outcomes in the National Mammography Database.
    Radiology. 2018 Jan 9:170770. doi: 10.1148/radiol.2017170770.
    PubMed     Text format     Abstract available

  50. HENDRICK RE
    Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Radiology. 2017 Dec 21:171622. doi: 10.1148/radiol.2017171622.
    PubMed     Text format     Abstract available

  51. NEUSCHLER EI, Butler R, Young CA, Barke LD, et al
    A Pivotal Study of Optoacoustic Imaging to Diagnose Benign and Malignant Breast Masses: A New Evaluation Tool for Radiologists.
    Radiology. 2017 Nov 27:172228. doi: 10.1148/radiol.2017172228.
    PubMed     Text format     Abstract available

  52. IIMA M, Kataoka M, Kanao S, Onishi N, et al
    Intravoxel Incoherent Motion and Quantitative Non-Gaussian Diffusion MR Imaging: Evaluation of the Diagnostic and Prognostic Value of Several Markers of Malignant and Benign Breast Lesions.
    Radiology. 2017 Nov 2:162853. doi: 10.1148/radiol.2017162853.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: